News
Local
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate News
Hot Property
eNewspaper
________________
Subscriptions
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
About Us
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Events
Advertising
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Jobs
CaregiverSD
Community papers
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Games, Puzzles, and Crossword
Crossword
Sudoku
Crossword
Sudoku
Obituaries
Death Notices
Place an obituary
Death Notices
Place an obituary
U-T En Español
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Privacy and Terms
Privacy
Terms
Advertising terms
Privacy
Terms
Advertising terms
Copyright © 2022, The San Diego Union-Tribune |
CA Notice of Collection
|
Do Not Sell My Personal Information
Sections
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate
Obituaries
eNewspaper
Newsletters
Show Search
Search Query
Submit Search
COVID-19
For subscribers
Phenomenal women
Latino life
Crossword
Sudoku
About Us
Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Diego Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Purple Biotech Ltd. - American Depositary Shares
(NQ:
PPBT
)
4.550
-0.400 (-8.08%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Apr 23, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Purple Biotech Ltd. - American Depositary Shares
< Previous
1
2
3
4
5
6
Next >
Purple Biotech Debuts Scientific Advisory Board
April 25, 2023
From
Purple Biotech Ltd.
Via
GlobeNewswire
Purple Biotech Reports New Preclinical Data on Potential of NT219 to Re-sensitize Resistant Tumors to Immune Checkpoint Inhibitors
April 19, 2023
From
Purple Biotech Ltd.
Via
GlobeNewswire
Purple Biotech to Participate in Canaccord Genuity's 2023 Horizons in Oncology Virtual Conference
April 18, 2023
From
Purple Biotech Ltd.
Via
GlobeNewswire
Purple Biotech's Assets Are First In Class For Solid Tumor Treatment, Analyst Says
↗
October 17, 2022
Via
Benzinga
This Small-Cap Cancer Stock Has Almost 400% Upside According To This Bullish Analyst
↗
September 08, 2022
Via
Benzinga
Purple Biotech Reports Temporary Medical Leave of CEO Gil Efron
March 24, 2023
From
Purple Biotech Ltd.
Via
GlobeNewswire
Purple Biotech Reports Biomarker Data from CM24 Phase 1 Dose Escalation Study
March 16, 2023
From
Purple Biotech Ltd.
Via
GlobeNewswire
Purple Biotech Announces First Patient Dosed in Open Label, Randomized Part of CM24 Phase 2 Clinical Trial
February 14, 2023
From
Purple Biotech Ltd.
Via
GlobeNewswire
Purple Biotech Expands Pipeline of First-in-Class Therapeutics with Acquisition of Immunorizon and Its Portfolio of Tri-Specific Antibodies for the Treatment of Cancer
February 02, 2023
From
Purple Biotech Ltd.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
February 01, 2023
Via
Benzinga
Purple Biotech and Mor Research Applications Announce Research Collaboration to Identify Promising Investigational Oncology Treatments
January 03, 2023
As a subsidiary of Clalit Healthcare Services, Israel’s largest HMO, Mor Research Applications brings Purple Biotech first access to research conducted at 14 hospitals The collaboration with Mor...
From
Purple Biotech Ltd.
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Thursday
↗
December 08, 2022
During Thursday's trading, 138 companies set new 52-week lows.
Via
Benzinga
Purple Biotech Presents New Data on Mechanism of Action for CM24 at the AACR Special Conference: Cancer Metastasis
November 15, 2022
From
Purple Biotech Ltd.
Via
GlobeNewswire
Purple Biotech to Present at the Jefferies London Healthcare Conference
November 10, 2022
From
Purple Biotech Ltd.
Via
GlobeNewswire
Purple Biotech Appoints Lior Fhima as Chief Financial Officer
November 02, 2022
From
Purple Biotech Ltd.
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For October 17, 2022
↗
October 17, 2022
Upgrades
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
October 12, 2022
Gainers
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 8, 2022
↗
September 08, 2022
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
July 21, 2022
Gainers Hanger (NYSE:HNGR) stock moved upwards by 27.1% to $18.75 during Thursday's after-market session. The company's market cap stands at $731.7 million.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
July 05, 2022
Gainers NeuroBo Pharmaceuticals (NASDAQ:NRBO) stock rose 14.5% to $0.53 during Tuesday's after-market session. The company's market cap stands at $14.0 million.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
May 26, 2022
Gainers
Via
Benzinga
34 Stocks Moving In Thursday's Mid-Day Session
↗
March 24, 2022
Gainers JX Luxventure Limited (NASDAQ: LLL) shares jumped 37.7% to $4.64. Emclaire Financial Corp (NASDAQ: EMCF) shares climbed 32.8% to $38.35 after the company and...
Via
Benzinga
63 Biggest Movers From Yesterday
↗
March 25, 2022
Gainers InMed Pharmaceuticals Inc. (NASDAQ: INM) shares gained 39.1% to close at $1.05 on Thursday. The company recently said its CFO Bruce Colwill will retire. Global Internet...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
↗
March 24, 2022
Good morning, trader! It's time for another round of the biggest pre-market stock movers before the opening bell on Thursday!
Via
InvestorPlace
20 Stocks Moving in Thursday's Pre-Market Session
↗
March 24, 2022
Gainers Mercurity Fintech Holding Inc. (NYSE: MFH) rose 91% to $4.03 in pre-market trading. Energy Services of America Corporation (NASDAQ: ESOA) shares rose 40% to $4.62 in pre-...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
March 08, 2022
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
↗
June 07, 2021
Gainers Atossa Therapeutics (NASDAQ:ATOS)...
Via
Benzinga
35 Stocks Moving In Monday's Mid-Day Session
↗
June 07, 2021
Gainers Ra Medical Systems, Inc. (NYSE: RMED) shares jumped 64.8% to $8.04 on abnormally-high session volume. EXFO Inc. (NASDAQ: EXFO) surged 60.3% to $5.93 after the company...
Via
Benzinga
70 Biggest Movers From Yesterday
↗
July 30, 2021
Gainers Xenetic Biosciences, Inc. (NASDAQ: XBIO) shares surged 65.1% to settle at $5.30 on Thursday. Xenetic Biosciences recently reported closing of $12.5 million private...
Via
Benzinga
60 Biggest Movers From Yesterday
↗
June 08, 2021
Gainers Ra Medical Systems, Inc. (NYSE: RMED) shares surged 87.3% to close at $9.14 on Monday on abnormally-high session volume. EXFO Inc. (NASDAQ: EXFO) gained 60.3% to settle...
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.